Life Sciences

Global Leaders in Life Sciences
  • Access to Capital - $1.1 billion in equity capital raised in 2016
  • Liquid Trading Market - More than 6.4 billion Life Sciences shares were traded in 2016 with a total value of $28 billion
  • Analyst Coverage - Four out of five TSX listed Life Sciences companies are covered by an analyst
  • Tailored & Flexible Listing Criteria - Listing criteria focuses on evidence of adequate financing and operational expertise to carry the company forward with its intended development program
  • Growth Potential - TSXV Issuers can graduate to TSX as the company fulfills its growth strategy

Sector Activity at a Glance – YTD December 31, 2016

December 2016TSXVTSXTSXV and TSX
Number of Issuers 85 43 128
QMV (C$) 3,720,103,763 20,497,883,699 24,217,987,461
New Listings 13 6 19
Equity Capital Raised (C$) 295,049,138 821,521,378 1,116,570,516
Number of Financings 74 40 114
Volume Traded 3,147,663,816 3,305,046,197 6,452,710,013
Value Traded (C$) 3,879,443,180 24,198,689,120 28,078,132,300
# of Trades 1,308,094 5,450,497 6,758,590

Sector Information

For more information on Toronto Stock Exchange and TSX Venture Exchange listed companies, please refer to our Current Market Statistics.

Indices

S&P/TSX Capped Health Care Index

Information

To learn more about listing in the Life Sciences sector on TSX/TSXV, please contact:

Michael Kousaie
Head, Business Development, Life Sciences
+1 416 947-6626
michael.kousaie@tsx.com

Business Development - Asia
(86) 1065 05 8011
asia@tsx.com

Business Development - Europe & Africa
emea@tsx.com

Follow us on Twitter: @tsx_tsxv

v x